Vaccine Resources

Park County COVID19 Vaccine Resources

Upcoming Clinics: 

The clinics have Moderna, Pfizer and Johnson & Johnson vaccines available for first, second, third and booster doses for eligible populations. Appointments and walk-ins accepted.

  • May 21 - Fairplay Community Center 880 Bogue St., Fairplay CO 80440 Register here. 10 AM - 2 PM
  • May 22 - Park County Government Building, 59961 US Hwy 285, Bailey, CO 80421.  Register here. 12 - 5 PM 

Please bring your vaccine card(s) if this is not your first dose. Parent or guardian consent is required for minors. Please find links, resources and more information here.  

Other Vaccine Clinic Resources and Options

The following information has been provided by each hospital system, facility, or provider regarding vaccine distribution plans and options for patients. Please visit their websites to learn more:

CDC RECOMMENDS PFIZER VACCINE FOR 5-11 YEAR OLDS

On Nov. 2, the Centers for Disease Control and Prevention (CDC) gave a final approval for use of the Pfizer COVID-19 vaccine for 5-11 year olds. 

Many of the current vaccine sites will carry the pediatric Pfizer vaccines, please check availability when registering for an appointment.  If you have questions, please speak with your child's pediatrician. Also visit the CDC's COVID vaccine website for children and teens. 

Parent or guardian consent is required. Locations, details and resources here:

Fourth Dose Recommended for People 50 and Older with Higher-Risk

On March 28, CDC said people over the age of 50 can now get an additional booster 4 months after their prior dose to increase their protection from COVID-19. This is especially important for those 65 and older and those 50 and older with underlying medical conditions that increase their risk for severe disease from COVID-19 as they are the most likely to benefit from receiving an additional booster dose at this time. 

Third Dose Recommended for Everyone 12 and Older

The CDC updated the recommended timeline for when people can get a third Pfizer-BioNTech or Moderna vaccine dose, shortening the minimum interval from six months to five months. 

The CDC also updated their recommendation for a third dose of Pfizer-BioNTech to include adolescents age 12 to 17.  At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized for adolescents aged 12-17. Everyone 12 and older should get a booster dose at least:

  • Five months after completing the Pfizer primary vaccination series,
  • Six months after completing the Moderna primary vaccination series, or
  • Two months after receiving the single-dose Johnson & Johnson vaccine.

On December 9, CDC recommended people ages 16-17 also receive a booster of the COVID-19 vaccine for continued protection. Please see here for more details. 

On Oct. 21, the Centers for Disease Control and Prevention (CDC) recommended Moderna and Janssen (Johnson & Johnson) COVID-19 vaccine booster doses for people at higher risk for COVID-19. 

CDC also authorized a “mix and match” approach to booster doses. People may get a different type of vaccine for their booster than their original series. For example, if you received a Johnson & Johnson vaccine for your first dose, you may choose to get a booster dose of Pfizer, Moderna, or Johnson & Johnson.  

Electronic Proof of COVID19 Vaccine

Do you need proof of your COVID-19 vaccine? You can visit the the state's website and save an electronic version of the same format as the paper CDC card the user received when they were vaccinated. myColorado app users can download a copy to their device, refresh or delete the record.

Vaccine Types

Safety and Monitoring:

  • On July 13, the FDA published a press release and sent a fact sheet and another fact sheet to healthcare providers (i.e.doctors, nurses, hospitals, etc.) about a recent safety signal they detected: Guillain-Barre Syndrome (GBS). Based on an analysis of Vaccine Adverse Event Reporting (VAERS) data, the FDA found 100 reports of GBS following 12.5 million vaccines. Out of the 100 cases, 95% were serious and required hospitalization. One person died.
  • On June 23, CDC issued a safety concern associated with Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination
  • On April 23, the press release from the FDA and CDC, who determined the use of the Janssen COVID-19 Vaccine should be resumed in the United States and that the FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19. CDPHE has decided to proceed by including FDA’s updated warning to patients about the increased risk of very rare but potentially severe TTS, particularly among women under the age of 50.
  • On August 23, the  FDA granted full approval to the Pfizer COVID19 vaccine for ages 16 and older, marking an important milestone in the ongoing pandemic.
  • On August 11, the CDC released additional safety data related to pregnant people receiving the COVID19 vaccine, more details can be found here: https://www.cdc.gov/media/releases/2021/s0811-vaccine-safe-pregnant.html
  • The Johnson & Johnson and Moderna vaccines are authorized for ages 18 and older and the Pfizer vaccine is approved for 12 and older. Please check the clinic you are registering for carefully to ensure it is offering your preferred choice.
  • On May 10, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer COVID-19 Vaccine for the prevention of COVID-19 to include adolescents 12 through 15 years of age. The FDA previously amended the EUA for administration in individuals 16 years of age and older. All ages are subject to change.
  • Vaccine Finder: allows you to search by vaccine type and location in Colorado.
  • Overview of approved vaccines

Who Shouldn't Get a Vaccine?

The vaccines have received Emergency Use Authorization (EUA) by the FDA and are considered highly safe and effective at preventing COVID-19 infections. Most people 12 years and older (for Pfizer) and 18 and older (for Moderna and Johnson and Johnson vaccines) are able to safely receive the vaccine, but please contact your doctor if you:

  • Are currently in isolation or have a fever 24 hours after the end of isolation with no improvement in symptoms
  • Had a severe allergic reaction after a previous dose of this vaccine
  • Have had a severe allergic reaction to any ingredient of this vaccine.

A Compilation of Vaccine Resources and Information

The development and distribution a COVID-19 vaccine will require a large scale effort by state, local, and private sector partners. The first phase will focus on frontline health care workers, first responders, and our most vulnerable populations living in long-term care facilities. Until the vaccine is widely available to the general public, we all need to continue to follow critical public health protocols. Please wear a mask in public, maintain at least 6 feet of distance from others, avoid gatherings, wash your hands often, and stay home when you are sick.

Background:

Scientists have developed several possible vaccines to provide immunity to COVID-19.  Once a company develops a vaccine, it must go through a rigorous scientific testing process before it can be submitted to the Food and Drug Administration (FDA). The FDA independently reviews the information from these tests to make sure the vaccine is safe and works well, and then decides whether the vaccine can be licensed and made available to the public. The pharmaceutical companies Pfizer and Moderna have applied for an Emergency Use Authorization with the Food and Drug Administration (FDA). The FDA authorized the Pfizer vaccine for emergency use on December 11, and Colorado received the vaccine beginning December 14. Moderna vaccine is expected to arrive in Colorado the week of December 22.
Safety and Effectiveness:
The companies report that both vaccines are around 95% effective. While the development process was efficient, the world's leading vaccine companies, in conjunction with the FDA and independent scientists, have used the same rigorous structure to develop these vaccines as has been used for all other drug and vaccine development. These involve multiple studies or “phased trials” across many months with larger and larger groups of people to ensure that the vaccine is both safe and effective for the general public. Tens of thousands of individuals across the US and the world have volunteered and helped provide this important information.

About mRNA-1273, Moderna’s Vaccine Against COVID-19:

The Moderna vaccine, or mRNA-1273 works by helping the immune system produce effective antibodies against the SARS-CoV-2 virus so that, in case of infection, the virus does not cause illness. The vaccine cannot cause infection or make someone sick with COVID-19. Learn more about the Moderna vaccine safety and effectiveness by the FDA here.

Two-Dose Vaccines:

Both mRNA vaccines require two injections, given either 21 or 28 days apart. The first dose primes the immune system and the second dose helps boost the immune system even further to help provide better protection against the coronavirus. Two shots spaced apart are necessary as the Pfizer vaccine has been shown to be 95% effective after an individual receives 2 doses, however, only 52% effective if an individual receives just a single dose.


Other Trusted Resources

CDC Resources

Advisory Committee on Immunization Practices (ACIP) Guidelines

Colorado Resources

Other Vaccine Information